Urolithin A and Mitochondrial Biogenesis

Your cells don't just keep the mitochondria they're born with. They constantly tear down worn-out ones and build fresh ones in their place. That second half — building new mitochondria — is called mitochondrial biogenesis, and understanding how it relates to urolithin A clears up one of the most common points of confusion about this molecule.

Biogenesis: how a cell builds new power plants

Mitochondria are the organelles that turn the food you eat and the oxygen you breathe into ATP, the energy currency every cell runs on. A single muscle or heart cell can hold hundreds to thousands of them. But mitochondria wear out. The same oxygen-handling chemistry that makes them useful also generates reactive byproducts that damage their membranes, proteins, and their own small loop of DNA over time. To keep energy output steady, a cell has to replace what it loses — and that replacement program is mitochondrial biogenesis.

Biogenesis is not the creation of a mitochondrion from nothing. Existing mitochondria grow and divide, adding membrane, importing newly made proteins, and copying their DNA. The whole process is coordinated by a master regulator protein called PGC-1α (peroxisome proliferator-activated receptor gamma coactivator 1-alpha). When PGC-1α is switched on, it activates downstream transcription factors — NRF-1 and NRF-2 (nuclear respiratory factors) and TFAM (mitochondrial transcription factor A) — that together turn on the hundreds of genes needed to assemble a functioning mitochondrion and to replicate mitochondrial DNA. Upstream, two energy-sensing enzymes, AMPK and SIRT1, help flip the PGC-1α switch when a cell senses it needs more energy capacity.

This is why exercise is such a powerful driver of biogenesis. When you train, especially with endurance work, your muscles burn through ATP faster than they can make it. The resulting rise in AMP and shifts in cellular fuel status activate AMPK and SIRT1, which activate PGC-1α, which tells the cell to build more mitochondria. Repeat that signal across weeks of training and the muscle ends up with measurably more mitochondrial content than it started with.

Mitophagy: the other half of the cycle

Biogenesis only tells half the story. Building new mitochondria is useful only if the cell is also clearing out the broken ones. That cleanup process is called mitophagy — a specialized form of autophagy ("self-eating") in which a cell tags a damaged mitochondrion, wraps it in a membrane, and delivers it to the lysosome to be broken down and recycled. You can read a fuller explanation in our guides to what mitophagy is and how autophagy and mitophagy differ.

Biogenesis and mitophagy are two sides of one coin: mitochondrial turnover. A healthy cell keeps these in balance, retiring damaged units through mitophagy and replacing them through biogenesis so the overall pool stays young and efficient. When that balance tips — when damaged mitochondria accumulate faster than they're cleared, or new ones aren't built fast enough — the cell's average mitochondrial quality drifts downward. Researchers consider this gradual decline in mitochondrial turnover one of the features of cellular aging, closely tied to the drop in energy capacity many people notice as the decades pass.

Where urolithin A actually fits

Here is the key distinction, because it is where most of the confusion lives. Urolithin A is best characterized as a mitophagy inducer, not primarily a biogenesis stimulator. Its most-studied job is helping the cell with the recycling side of the cycle — clearing out damaged mitochondria — rather than directly flipping the PGC-1α switch the way exercise does.

The foundational work here is preclinical. In a widely cited 2016 study in Nature Medicine, Ryu and colleagues showed that urolithin A induced mitophagy and improved mitochondrial and muscle function in the nematode C. elegans and in rodents, and extended lifespan in the worm model. This is animal and cell research — it establishes the mechanism and is genuinely foundational, but it is not proof of the same effect in humans, and it should be read as the starting point rather than the finish line.

On the human side, the evidence base is narrower and focused on function rather than on biogenesis markers directly. The first-in-human trial, Andreux and colleagues in Nature Metabolism (2019), found urolithin A was safe and well tolerated at doses up to 1,000 mg per day and induced a mitochondrial gene-expression signature in the blood and muscle of older adults. Later randomized controlled trials — Singh and colleagues in Cell Reports Medicine (2022) in middle-aged adults, and Liu, D'Amico and colleagues in JAMA Network Open (2022) in older adults — reported changes in muscle strength, endurance, and exercise-related markers over roughly four months. These point to effects on how mitochondria work, measured through performance and molecular signatures, rather than to a demonstrated increase in the raw number of mitochondria built through classical PGC-1α biogenesis.

Why the two processes work better together

If biogenesis builds new mitochondria and mitophagy clears the damaged ones, it follows that supporting both sides at once is more sensible than chasing either alone. Exercise is still the most reliable, best-evidenced way to stimulate biogenesis in humans — nothing in a bottle replaces that. What urolithin A offers, based on its mechanism, is support for the recycling side that keeps the existing pool clean, so the mitochondria you build through training and daily movement are working against a less cluttered background.

This is also why urolithin A is not a stimulant and doesn't produce a felt "kick." It isn't pushing your cells to run hotter; it's associated with housekeeping. Benefits that show up in trials tend to appear gradually, over weeks to months, which fits a mechanism based on cellular maintenance rather than acute energy release. If you want the deeper science, our complete urolithin A guide walks through the full mechanism, and our roundup of the best urolithin A gummies covers what to look for in a product.

How biogenesis changes with age

PGC-1α signaling tends to become less responsive with age, and physical activity often declines too, so the biogenesis stimulus weakens from both directions. At the same time, mitophagy can slow, leaving more damaged mitochondria in place. The combined result is the shift in mitochondrial turnover researchers associate with lower cellular energy capacity in later decades. This is the backdrop against which much of the healthy-aging interest in urolithin A sits — not as a treatment for any condition, but as one input into the ongoing cellular maintenance that staying active supports most.

What this means for expectations

Setting realistic expectations matters. Urolithin A is a structure/function supplement that may support mitochondrial and muscle function; it is not a way to instantly multiply your mitochondria, and no supplement should be framed that way. The honest summary of the science is that the human evidence is promising but still early and centered on function and safety, the biogenesis-specific claims rest largely on preclinical work, and the most dependable lever for building mitochondria remains regular exercise.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This guide is educational and is not a substitute for advice from a qualified healthcare provider.